In this Eastern Cooperative Oncology Group (ECOG) phase II study, dibromodulcitol (DBD) and a combination of actinomycin D, hydroxyurea, and cyclophosphamide (AHC) were compared with methyl-CCNU, the current ECOG standard, in patients who had received no prior chemotherapy for disseminated malignant
โฆ LIBER โฆ
Induced remission of malignant melanoma with actinomycin D. Immunologic implications
โ Scribed by Frederick M. Golomb; Alex C. Solowey; Allen Postel; Stephen L. Gumport; Jane C. Wright
- Book ID
- 102666092
- Publisher
- John Wiley and Sons
- Year
- 1967
- Tongue
- English
- Weight
- 630 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Phase II evaluation of dibromodulcitol a
โ
David A. Amato; Howard Bruckner; DuPont Guerry; Arlene Ash; Geoffrey Falkson; Er
๐
Article
๐
1987
๐
Springer US
๐
English
โ 418 KB
Dermatomyositis associated with malignan
โ
Thomas D. Sunnenberg; Craig S. Kitchens
๐
Article
๐
1983
๐
John Wiley and Sons
๐
English
โ 203 KB
๐ 2 views
Hyperthermic regional perfusion with mel
โ
H. Martijn; J. Oldhoff; H. Schraffordt Koops
๐
Article
๐
1982
๐
John Wiley and Sons
๐
English
โ 443 KB
## Abstract From September 1969 through 1979, 68 patients with already locally metastasized malignant melanomas of the extremities were treated by hyperthermic regional perfusion and local excision(s). Of these, 53 patients could be evaluated after a followโup of at least 2 years: 31 had been perfu